MCID: PTY002
MIFTS: 32

Pityriasis Versicolor malady

Category: Infectious diseases

Aliases & Classifications for Pityriasis Versicolor

About this section

Aliases & Descriptions for Pityriasis Versicolor:

Name: Pityriasis Versicolor 11 50 13
Tinea Versicolor 39 68
 
Infection by Pityrosporum Furfur 11

Classifications:



External Ids:

Disease Ontology11 DOID:9060
ICD1030 B36.0
ICD9CM32 111.0
SNOMED-CT62 154395007, 56454009
MeSH39 D014010

Summaries for Pityriasis Versicolor

About this section
Disease Ontology:11 A superficial mycosis that is a chronic, superficial fungal infection of the skin caused by Malassezia furfur, which is characterized by well-demarcated white, pink, fawn, or brownish lesions, often coalescing, and covered with thin furfuraceous scales.

MalaCards based summary: Pityriasis Versicolor, also known as tinea versicolor, is related to epidermodysplasia verruciformis and dermatitis. An important gene associated with Pityriasis Versicolor is CAT (Catalase), and among its related pathways The drugs econazole and ketoconazole have been mentioned in the context of this disorder. Affiliated tissues include skin, and related mouse phenotype Decreased shRNA abundance (Z-score < -2).

Related Diseases for Pityriasis Versicolor

About this section

Diseases related to Pityriasis Versicolor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 20)
idRelated DiseaseScoreTop Affiliating Genes
1epidermodysplasia verruciformis11.1
2dermatitis10.3
3erythrasma10.1
4seborrheic dermatitis10.1
5tinea cruris10.0
6atopic dermatitis10.0
7pityriasis rotunda10.0
8adrenal rest tumor9.9CAT, CBS
9atopy9.8
10leprosy9.8
11tinea corporis9.8
12tinea pedis9.8
13candidiasis9.8
14tinea capitis9.8
15dermatophytosis9.8
16hansen's disease9.8
17ischemic neuropathy9.8CBS, SQLE
18cole-carpenter syndrome 19.6TMC6, TMC8
19acute diarrhea8.2CBS, CIC, STIM1, TMC6, TMC8
20leishmaniasis7.5CAT, CBS, CIC, SQLE, STIM1, TMC6

Graphical network of diseases related to Pityriasis Versicolor:



Diseases related to pityriasis versicolor

Symptoms & Phenotypes for Pityriasis Versicolor

About this section

GenomeRNAi Phenotypes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-589.1CBS, CIC

Drugs & Therapeutics for Pityriasis Versicolor

About this section

Drugs for Pityriasis Versicolor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 13)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
2
Ketoconazoleapproved, investigationalPhase 417465277-42-147576, 3823
Synonyms:
(+)-Ketoconazole
(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
(+-)-cis-1-acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1- ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
(+/-)-cis-1-Acetyl-4-(4-[(2-[2,4-dichlorophenyl]-2-[1H-imidazol-1-ylmethyl]-1,3-dioxolan-4-yl)-methoxy]phenyl)piperazine
(+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
65277-42-1
79156-75-5
AC-15957
AC1L9UG3
BIDD:GT0696
BIM-0050645.0001
BPBio1_000635
BRD-K29113274-001-03-6
BRN 4303081
BSPBio_000577
C26H28Cl2N4O4
CHEBI:48336
CHEMBL75
CID456201
CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE
CPD000058460
EINECS 265-667-4
EU-0100666
Extina
Fungarest
Fungoral
HMS1569M19
HMS2051A19
HMS2089N05
HSDB 7447
K 1003
K0045
K1003_SIGMA
KCZ
KS-1205
KTZ
KW-1414
KZ
Ketoconazol
Ketoconazole
Ketoconazole [USAN:INN:BAN:JAN]
Ketoconazolum
Ketoderm
Ketoisdin
Ketozole
 
LS-110149
Lopac0_000666
MLS000069784
MLS000758224
MLS001146934
MLS002207053
MLS002222255
MolPort-003-848-307
NCGC00025000-01
NCGC00025000-02
NCGC00025000-03
NCGC00025000-04
NCGC00025000-05
NCGC00025000-06
NCGC00025000-07
NCGC00025000-08
NCGC00025000-09
NSC 317629
NSC317629
Nizoral
Nizoral a-D
Nizoral, Extina, Xolegel, Kuric, Ketoconazole
Orifungal M
Panfungol
Piperazine
Prestwick0_000389
Prestwick1_000389
Prestwick2_000389
Prestwick3_000389
Prestwick_744
R 41,400
R 41400
R-41400
R41,400
R41400
S1353_Selleck
SAM001246983
SMR000058460
SPBio_002498
Tocris-1103
UC280_SIGMA
UPCMLD-DP138
UPCMLD-DP138:001
Xolegel
cis-1-Acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H- imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-ketoconazol
cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine
ketoconazole
3
Ciclopiroxapproved, investigationalPhase 41429342-05-02749
Synonyms:
(6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone)
29342-05-0
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone
6-Cyclohexyl-1-hydroxy-4-methyl-2-(1H)-pyridone
6-cyclohexyl-1-hydroxy-4-methyl-2(1 H )-pyridinone
6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one
6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one
AC-13011
AC1L1EDN
BIDD:GT0080
BPBio1_000641
BSPBio_000581
BSPBio_002041
C12H17NO2
CHEBI:453011
CHEMBL1413
CICLOPIROX
CID2749
Ciclopirox (USP/INN)
Ciclopirox Olamin
Ciclopirox [USAN:BAN:INN]
Ciclopirox gel
Ciclopirox-Olamin
Ciclopiroxolamine
Ciclopiroxum
Ciclopiroxum [INN-Latin]
D03488
DB01188
Dafnegin-CSC
EINECS 249-577-2
 
HOE 296b
HOE-296
HOE-296b
I06-0862
KBio3_001261
KBioGR_000816
LS-174247
Loprox
Loprox (TN)
Loprox Gel
Loprox Shampoo
Loprox cream
NCGC00178850-01
NCGC00178850-02
Penlac
Penlac (TN)
Penlac nail lacquer
Prestwick0_000541
Prestwick1_000541
Prestwick2_000541
Prestwick3_000541
SPBio_000252
SPBio_002502
Spectrum2_000146
Spectrum3_000351
Spectrum4_000288
Spectrum5_000747
Stieprox
TL8002303
Terit
UNII-19W019ZDRJ
cyclopirox
cyclopyroxolamine
4Steroid Synthesis InhibitorsPhase 41718
5Antifungal AgentsPhase 4, Phase 13615
6Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 412767
7Anti-Infective AgentsPhase 421402
8HormonesPhase 413979
9Cytochrome P-450 CYP3A InhibitorsPhase 41666
10Cytochrome P-450 Enzyme InhibitorsPhase 43822
11Hormone AntagonistsPhase 412778
12
Glucosamineapproved, NutraceuticalPhase 11823416-24-8439213
Synonyms:
(+)-2-amino-2-deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2-Amino-2-deoxy-D-Glucose
2-Amino-2-deoxy-D-glucopyranose
2-Amino-2-deoxy-D-glucose
2-Amino-2-deoxy-beta-D-glucopyranose
2-Amino-2-deoxyglucose
2-Aminoglucose
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-deoxyglucose
2351-15-7
28905-10-4
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58-87-7
58267-75-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
CID18897
CID439213
CID441477
CPD0-1193
Chitosamine
Cosamin
D-(+)-Glucosamine
 
D-Glucosamine
D-glucosamine
D04334
DB01296
DivK1c_000261
EINECS 222-311-2
GCS
Glucosamina
Glucosamina [INN-Spanish]
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosaminum
Glucosaminum [INN-Latin]
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
NINDS_000261
SPBio_000477
STK801823
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
Spectrum_000831
Viartril-S
beta-D-Glucosamine
bmse000247
chitosamine
glucosamine
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
13GinkgoNutraceuticalPhase 158

Interventional clinical trials:

idNameStatusNCT IDPhase
1Ketoconazole Foam 2% for the Treatment of VersicolorCompletedNCT00830388Phase 4
2Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in ChildrenTerminatedNCT01646580Phase 4
3Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea PedisRecruitingNCT02882438Phase 1

Search NIH Clinical Center for Pityriasis Versicolor

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: tinea versicolor

Genetic Tests for Pityriasis Versicolor

About this section

Anatomical Context for Pityriasis Versicolor

About this section

MalaCards organs/tissues related to Pityriasis Versicolor:

36
Skin

Publications for Pityriasis Versicolor

About this section

Articles related to Pityriasis Versicolor:

(show top 50)    (show all 254)
idTitleAuthorsYear
1
Clinicomycological profile of pityriasis versicolor in Assam. (27166032)
2016
2
Atrophying pityriasis versicolor as an idiosyncratic TA cell-mediated response to Malassezia: A case series. (27816291)
2016
3
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor. (27532525)
2016
4
Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial. (27559523)
2016
5
The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study. (27329971)
2016
6
In vitro antifungal susceptibility of Malassezia isolates from pityriasis versicolor lesions. (27852993)
2016
7
Pityriasis versicolor atrophicans mit epidermaler Atrophie. (27373255)
2016
8
A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor. (26419668)
2015
9
Pityriasis versicolor. (25852089)
2015
10
Dermoscopy as an ancillary tool for the diagnosis of pityriasis versicolor. (26568350)
2015
11
Pityriasis versicolor atrophicans: Is it true atrophy or pseudoatrophy? (26488217)
2015
12
SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL. (26422149)
2015
13
A Novel Contrast Stain for the Rapid Diagnosis of Pityriasis Versicolor: A Comparison of Chicago Sky Blue 6B Stain, Potassium Hydroxide Mount and Culture. (26288400)
2015
14
Neonatal pityriasis versicolor. (25742084)
2015
15
Study of the Distribution of Malassezia Species in Patients with Pityriasis Versicolor in Kolar Region, Karnataka. (26120178)
2015
16
Influence of systemic corticotherapy on the triggering of pityriasis versicolor. (24724729)
2014
17
Perineal and genital pityriasis versicolor due to Malassezia globosa. (24814165)
2014
18
A study of the prevalence and precipitating factors of pruritus in pityriasis versicolor. (24860771)
2014
19
Identification of Malassezia Species Isolated from Patients with Pityriasis Versicolor Using PCR-RFLP Method in Markazi Province, Central Iran. (26056657)
2014
20
Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial. (25674122)
2014
21
Molecular identification and prevalence of malassezia species in pityriasis versicolor patients from kashan, iran. (25485051)
2014
22
Pityriasis versicolor: an update on pharmacological treatment options. (24991691)
2014
23
A case of Becker's nevus with pityriasis versicolor. (24438156)
2014
24
Atrophying pityriasis versicolor. (24733760)
2014
25
Pityriasis versicolor: a case of resistance to treatment. (23432729)
2014
26
Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. (24746716)
2014
27
An analysis of the Malassezia species distribution in the skin of patients with pityriasis versicolor in Chengdu, China. (25177714)
2014
28
A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. (24802530)
2014
29
Can pityriasis versicolor be treated with 2% ketoconazole foam? (25007370)
2014
30
Atypical clinical manifestation of pityriasis versicolor in a young boy. (24819649)
2014
31
Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA , Brazil. (23739695)
2013
32
Vulvar Pityriasis Versicolor in an Immunocompetent Woman. (24270201)
2013
33
Identification and speciation of malassezia in patients clinically suspected of having pityriasis versicolor. (23723483)
2013
34
Molecular epidemiology of Malassezia globosa and Malassezia restricta in Sudanese patients with pityriasis versicolor. (23054329)
2013
35
Pityriasis versicolor: avoiding pitfalls in disease diagnosis and therapy. (23929053)
2013
36
Hair loss in pityriasis versicolor lesions: a descriptive clinicopathological study. (22575159)
2013
37
Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor. (23952012)
2013
38
Identification of Malassezia species isolated from patients with extensive forms of pityriasis versicolor in Siena, Italy. (23434513)
2013
39
Molecular analysis of Malassezia species isolated from Israeli patients with pityriasis versicolor. (23347312)
2013
40
Treatment of pityriasis versicolor with topical application of essential oil of Cymbopogon citratus (DC) Stapf - therapeutic pilot study. (23793205)
2013
41
Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital, Punjab. (23883714)
2013
42
Identification of Malassezia Species from Pityriasis Versicolor Lesions with a New Multiplex PCR Method. (24190515)
2013
43
Pityriasis versicolor during anti-TNF-I+ monoclonal antibody therapy: therapeutic considerations. (22283428)
2012
44
Pityriasis versicolor on penile shaft in a renal transplant recipient. (22879720)
2012
45
Skin Characteristics in Patients with Pityriasis Versicolor Using Non-Invasive Method, MPA5. (23197911)
2012
46
Roles of adapalene in the treatment of pityriasis versicolor. (22572567)
2012
47
Pityriasis versicolor atrophicans. (22361878)
2012
48
Clinical efficacy and safety of a pharmacopial polyherbal Unani formulation in pityriasis versicolor: a comparative randomized single-blind study. (22871048)
2012
49
Prevalence of Malassezia species in patients with pityriasis versicolor in Rosario, Argentina. (21419859)
2012
50
Diagnosis of pityriasis versicolor in paediatrics: the evoked scale sign. (21030376)
2011

Variations for Pityriasis Versicolor

About this section

Expression for genes affiliated with Pityriasis Versicolor

About this section
Search GEO for disease gene expression data for Pityriasis Versicolor.

Pathways for genes affiliated with Pityriasis Versicolor

About this section

Pathways related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

   (show less)
idSuper pathwaysTop Affiliating Genes

GO Terms for genes affiliated with Pityriasis Versicolor

About this section

Cellular components related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulumGO:00057839.2CAT, STIM1, TMC6, TMC8
2endoplasmic reticulum membraneGO:00057898.5SQLE, STIM1, TMC6, TMC8

Biological processes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cholesterol metabolic processGO:000820310.4CAT, SQLE
2ion transportGO:00068119.5TMC6, TMC8

Molecular functions related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1heme bindingGO:00200379.6CAT, CBS

Sources for Pityriasis Versicolor

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet